FPR2 Antibodies

Santa Cruz Biotechnology features a diverse variety of FPR2 monoclonal antibodies for investigating formyl peptide receptor 2 (FPR2) in various biological processes. FPR2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FPR2 is a G protein-coupled receptor with essential functions in immune response, particularly in mediating the effects of formylated peptides released by bacteria and damaged tissues. The receptor's involvement in chemotaxis, inflammation, and immune cell activity regulation makes it a significant focus in immunology research. FPR2 research has revealed important connections to autoimmune disorders and cancer development. Studying FPR2 expression and activity patterns helps researchers better understand cellular signaling pathways and inflammatory responses. Advanced research techniques and reliable detection methods continue to expand knowledge about FPR2's role in disease progression and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of FPR2's role in human health and disease.